Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hodgkin Disease × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Breast 1

Conditions

Motor Activity 201 Breast Neoplasms 111 Neoplasms 88 Prostatic Neoplasms 33 Fatigue 28 Obesity 22 Colorectal Neoplasms 19 Lung Neoplasms 16 Colonic Neoplasms 15 Polycystic Ovary Syndrome 14 Ovarian Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma 10 Lymphedema 10 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Weight Loss 8 Multiple Myeloma 8 Leukemia 8 Hematologic Neoplasms 8 Cardiotoxicity 8 Pancreatic Neoplasms 7 Insulin Resistance 7 Carcinoma, Non-Small-Cell Lung 7 Cognitive Dysfunction 6 Brain Neoplasms 6 Overweight 5 Inflammation 5 Cachexia 5 Stomach Neoplasms 4

Interventions

Cyclophosphamide 154 fludarabine phosphate 96 Peripheral Blood Stem Cell Transplantation 80 Etoposide 77 Mycophenolic Acid 74 Whole-Body Irradiation 71 Melphalan 62 fludarabine 59 Tacrolimus 59 Filgrastim 59 Busulfan 58 Radiotherapy 52 Doxorubicin 50 Rituximab 49 Cyclosporine 47 Brentuximab Vedotin 44 Antilymphocyte Serum 40 Vinblastine 38 Granulocyte Colony-Stimulating Factor 37 Gemcitabine 34 Dacarbazine 33 Methotrexate 32 Cytarabine 32 Bleomycin 28 Nivolumab 26 Carmustine 26 Vincristine 24 Sirolimus 24 Prednisone 24 Bendamustine Hydrochloride 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05595577 2026-02-19

PALS

Wake Forest University Health Sciences

Phase NA Recruiting

Breast Neoplasms, Hodgkin Disease, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡